A federal appeals court yesterday upheld a win for Medtronic (NYSE:MDT) in a patent dispute over its CoreValve aortic valve replacement with inventor Dr. Troy Norred, according to legal filings. The physician’s 2013 patent infringement lawsuit, filed in the U.S. District Court for Kansas, was stayed until a trio of inter partes reviews by the U.S. Patent & Trademark Office’s […]
A clinical study of nearly 1,000 patients implanted with Medtronic‘s (NYSE:MDT) CoreValve replacement heart valve found a low rate of stroke out to 2 years. The study, published last month in the Journal of the American College of Cardiology, evaluated patients for neurological events over 3 periods after the procedure to implant the CoreValve transcatheter aortic […]
April 21, 2014 by Brad Perriello
UPDATED April 21, 2014, at 12:30 p.m. with comment from Medtronic.
UPDATED April 21, 2014, at 3:45 p.m. with comment from Edwards Lifesciences.
UPDATED Nov. 13, 2012, 5:30 p.m. with comment from Medtronic
UPDATED Nov. 13, 2012, 2:30 p.m. with comment from Edwards Lifesciences
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Edwards Lifesciences Inc. (NYSE:EW) won a major round in its patent war with Medtronic Inc. (NYSE:MDT) subsidiary CoreValve when a Delaware federal jury ruled that CoreValve willfully infringes an Edwards patent.